首页 | 本学科首页   官方微博 | 高级检索  
     

18F-FDG PET/CT显像中肝脏弥漫性摄取增高的鉴别诊断
引用本文:王振光,杨光杰. 18F-FDG PET/CT显像中肝脏弥漫性摄取增高的鉴别诊断[J]. 国际放射医学核医学杂志, 2020, 44(10): 655-660. DOI: 10.3760/cma.j.cn121381-201906019-00076
作者姓名:王振光  杨光杰
作者单位:青岛大学附属医院核医学科PET/CT中心 266100
摘    要:肝脏摄取状态常作为18F-氟脱氧葡萄糖(FDG)PET/CT显像时图像质量评价、疗效评估和病变诊断的参照标准。但有时肝脏呈弥漫性、均匀性或非均匀性18F-FDG摄取增高,被称为“超级肝显像”。除生理和技术因素影响外,各种弥漫性肝实质疾病和肝脏恶性肿瘤都可导致肝脏对18F-FDG的摄取增高。笔者就此进行综述,旨在为临床鉴别诊断拓展思路。

关 键 词:正电子发射断层显像术   氟脱氧葡萄糖F18   肝疾病   体层摄影术,X线计算机   超级肝显像
收稿时间:2019-06-14

Differential diagnosis of hepatic diseases with diffuse hepatic uptake increased in 18F-FDG PET/CT imaging
Zhenguang Wang,Guangjie Yang. Differential diagnosis of hepatic diseases with diffuse hepatic uptake increased in 18F-FDG PET/CT imaging[J]. International Journal of Radiation Medicine and Nuclear Medicine, 2020, 44(10): 655-660. DOI: 10.3760/cma.j.cn121381-201906019-00076
Authors:Zhenguang Wang  Guangjie Yang
Affiliation:PET/CT Center of Nuclear Medicine Department, the Affiliated Hospital of Qingdao University, Qingdao 266100, China
Abstract:Hepatic uptake is often used as the reference standard for the evaluation of image quality, therapeutic efficiency and diagnosis of diseases in 18F-fluorodeoxyglucose (FDG) PET/CT imaging. However, the liver shows diffuse, homogeneous or heterogeneous high 18F-FDG uptake sometimes, called hepatic superscan. Except for biologic and technical factors, many diffuse hepatic parenchymal diseases and malignancies may increased the uptake of 18F-FDG by the liver. This paper reviews this in order to widen the view in clinical differential diagnosis.
Keywords:
点击此处可从《国际放射医学核医学杂志》浏览原始摘要信息
点击此处可从《国际放射医学核医学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号